Table 5.
Practice of pharmacovigilance of HCPs between the intervention and control groups, before and after the intervention, n (%).
| Practice items | Preintervention |
Postintervention |
||||
|---|---|---|---|---|---|---|
| Intervention (n = 524) |
Control (n = 287) |
p value | Intervention (n = 596) | Control (n = 335) |
p value | |
| Training on ADR | 84 (16.0) | 43 (15.0) | 0.821 | 145 (24.3) | 39 (11.6) | <0.001 |
| Observed ADR | 423 (80.7) | 240 (83.6) | 0.222 | 489 (82.0) | 246 (73.4) | <0.001 |
| Reported ADR | 166 (31.7) | 78 (27.2) | 0.394 | 188 (31.5) | 91 (27.2) | 0.256 |
| Use of the national reporting form * | 80 (49.4) | 18 (23.4) | <0.001 | 77 (41.0) | 18 (19.8) | <0.001 |
| Easy access of ADR forms * | 49 (29.5) | 10 (12.8) | <0.001 | 35 (18.6) | 9 (9.9) | 0.022 |
| Easy reporting with the ADR form * | 84 (50.6) | 16 (20.5) | <0.001 | 56 (29.8) | 17 (18.7) | <0.001 |
| Easy mode of returning ADR forms * | 16 (9.6) | 3 (3.8) | 0.003 | 34 (18.1) | 6 (6.6) | <0.001 |
*
The number of respondents who had reported an ADR is the denominator.
p value from Pearson chi-square test.
Bold numerals indicate significance.
ADR, adverse drug reaction.